Straumann 

$113.46
90
-$5.34-4.5% Wednesday 18:48

Statistics

Day High
132.6
Day Low
132.6
52W High
135
52W Low
93.18
Volume
1
Avg. Volume
320
Mkt Cap
0
P/E Ratio
45.87
Dividend Yield
1.12%
Dividend
1.27

Upcoming

Dividends

1.12%Dividend Yield
Apr 26
$1.27
Apr 25
$0.70
Apr 25
$0.47
Apr 24
$0.49
Apr 24
$0.44
10Y Growth
11.89%
5Y Growth
15.32%
3Y Growth
12.23%
1Y Growth
81.46%

Earnings

19AugExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.75
1.5
2.26
Expected EPS
1.974931182
Actual EPS
2.028844

Financials

13.66%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
3.29BRevenue
448.84MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SAUHF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Henry Schein
HSIC
Mkt Cap10.01B
Henry Schein distributes dental products and services, including dental reconstructive products, competing directly with Straumann's dental implants and prosthetics.
DENTSPLY Sirona
XRAY
Mkt Cap2.27B
Dentsply Sirona is a direct competitor in the dental supplies market, offering a wide range of dental products including dental implants and prosthetic solutions.
Align Technology
ALGN
Mkt Cap11.27B
Align Technology, known for its Invisalign system, competes in the dental market by offering orthodontic products that can be alternatives to traditional braces and, indirectly, to dental implants.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, while primarily focused on orthopedic reconstructive devices, also offers dental implant and related products, competing in the dental implant market.
Smith & Nephew
SNN
Mkt Cap12.08B
Smith & Nephew, known for its advanced wound management, orthopedics, and other medical devices, competes indirectly by offering products in the reconstructive space, including dental.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation, a leader in medical technology, offers a range of products that compete in the orthopedics market, which can indirectly affect the market for dental implants and reconstructive solutions.
Danaher
DHR
Mkt Cap145.98B
Danaher Corporation, through its dental segment, provides a broad portfolio of dental products, including dental implants and consumables, directly competing with Straumann.
3M
MMM
Mkt Cap86.93B
3M, through its Health Care business, offers dental products and solutions, including dental adhesives and restoratives, indirectly competing with dental implants and prosthetics.
Envista
NVST
Mkt Cap4.38B
Envista Holdings Corporation, spun off from Danaher, operates in the dental products sector, offering comprehensive dental solutions that compete with Straumann's offerings.

About

Straumann Holding AG is a global provider of dental solutions, specializing in restoring and correcting teeth. The company is actively involved in the research, development, production, and distribution of a comprehensive portfolio of dental products. These include advanced dental implants, specialized instruments, CAD/CAM-designed prosthetics, clear orthodontic aligners, biomaterials, and various digital tools. These offerings are designed to address tooth correction, replacement, and restoration, alongside preventative dental care. Its extensive product range features diverse dental implant systems, available in both tissue and bone-level designs and crafted from materials like titanium, titanium alloy, or ceramic, including specialized mini implants. Straumann also supplies both guided and non-guided surgical instrument sets, along with prosthetics designed for integration with implants. Beyond implants, the company provides ceramic healing and screw-retained abutments, cutting-edge intraoral scanning devices, 3D printers, and milling machines, as well as preventative dental care products. Furthermore, Straumann is a provider of biomaterials such as bone substitutes, regenerative membranes, biologics, and solutions for soft tissue management and oral healing. Its digital solutions cater to dental laboratories, practitioners, and centralized milling facilities, encompassing specialized materials, third-party system integration, and guided surgery platforms. The surgical instrument range is comprehensive, featuring various cassettes (surgical and modular), guided instrumentation, implant maintenance tools, bone block fixation kits, bone rings, and titanium pin sets. For patients who have lost all their teeth (edentulous patients), Straumann provides a variety of solutions, including pro arch fixed restorations, advanced prosthetics, and mini implant systems. The company also offers aesthetic restoration options, such as ceramic implant monotypes, ceramic implants, cosmetic abutments, and biologics. Its portfolio also includes Emdogain, a product specifically designed for wound healing. Straumann additionally markets Clear Correct aligners for orthodontic treatment and provides extensive training and educational programs for its clientele. Its diverse customer base includes general dentists, dental specialists, and dental technicians/laboratories, along with corporate clients like distributors, hospitals, universities, and dental service organizations. Straumann distributes its products and services across roughly 100 countries, leveraging a robust network of distribution subsidiaries and strategic partners. Established in 1954, Straumann Holding AG maintains its corporate headquarters in Basel, Switzerland.
Show more...
CEO
Guillaume Daniellot
Employees
11824
Country
Switzerland
ISIN
CH1175448666
WKN
000A3DHHH

Listings

0 Comments

Share your thoughts

FAQ

What is Straumann stock price today?
The current price of SAUHF is $113.46 USD — it has decreased by -4.5% in the past 24 hours. Watch Straumann stock price performance more closely on the chart.
What is Straumann stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Straumann stocks are traded under the ticker SAUHF.
Is Straumann stock price growing?
SAUHF stock has fallen by -4.44% compared to the previous week, the month change is a -13.55% fall, over the last year Straumann has showed a -1.02% decrease.
When is the next Straumann earnings date?
Straumann is going to release the next earnings report on February 24, 2027.
What were Straumann earnings last quarter?
SAUHF earnings for the last quarter are 2.03 USD per share, whereas the estimation was 1.97 USD resulting in a +2.73% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Straumann revenue for the last year?
Straumann revenue for the last year amounts to 3.29B USD.
What is Straumann net income for the last year?
SAUHF net income for the last year is 448.84M USD.
Does Straumann pay dividends?
Yes, SAUHF dividends are paid annual. The last dividend per share was 1.27 USD. As of today, Dividend Yield (FWD)% is 1.12%.
How many employees does Straumann have?
As of September 10, 2026, the company has 11,824 employees.
In which sector is Straumann located?
Straumann operates in the Health & Wellness sector.
When did Straumann complete a stock split?
The last stock split for Straumann was on April 20, 2022 with a ratio of 10:1.
Where is Straumann headquartered?
Straumann is headquartered in Basel, Switzerland.